Literature DB >> 21818629

Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes.

J Angst1, A Gamma, C L Bowden, J M Azorin, G Perugi, E Vieta, A H Young.   

Abstract

To assess the clinical validity of individual DSM-IV criteria for hypomania. In an international sample of 5,635 patients with major depressive episodes (Bridge Study), DSM-IV criteria for hypomania (stem questions, number and quality of symptoms, duration and exclusion criteria) were systematically assessed and their validity analysed on the basis of clinical data including family history, course, and other clinical characteristics. Three stem questions for hypomania, irritability, elevated mood and the added question of increased activity, showed comparable validity. The results support the current DSM-IV requirement for a higher symptom threshold (4 of 7 hypomanic symptoms) in cases of irritable mood. Longer durations of hypomanic episodes were associated with higher scores on all validators. The results did not support the DSM-IV durational requirements for hypomanic episodes (4 days) and manic episodes (7 days). Brief hypomanic episodes of 1, 2 or 3 days were valid and would meet validity criteria for inclusion. The three exclusion criteria in DSM-IV (hypomania due to the use of antidepressants or of other substances, or to other medical conditions) were found to exclude patients with bipolar depression and should therefore not be retained. These results support several revisions of the DSM-IV concept of hypomanic episodes: specifically, the inclusion of increased activity as a gate question, the inclusion of 1 or 2 to 3-day episodes and the elimination of all exclusion criteria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818629     DOI: 10.1007/s00406-011-0228-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  17 in total

1.  Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.

Authors:  Jules Angst; Jean-Michel Azorin; Charles L Bowden; Giulio Perugi; Eduard Vieta; Alex Gamma; Allan H Young
Journal:  Arch Gen Psychiatry       Date:  2011-08

2.  Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation.

Authors:  Brendan A Rich; Mariana Schmajuk; Koraly E Perez-Edgar; Nathan A Fox; Daniel S Pine; Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2007-02       Impact factor: 18.112

3.  Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication.

Authors:  Jules Angst; Lihong Cui; Joel Swendsen; Stéphane Rothen; Anibal Cravchik; Ronald C Kessler; Kathleen R Merikangas
Journal:  Am J Psychiatry       Date:  2010-08-16       Impact factor: 18.112

Review 4.  Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.

Authors:  Harm J Gijsman; John R Geddes; Jennifer M Rendell; Willem A Nolen; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

5.  Rapid onset of comorbidity of common mental disorders: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  R de Graaf; R V Bijl; M ten Have; A T F Beekman; W A M Vollebergh
Journal:  Acta Psychiatr Scand       Date:  2004-01       Impact factor: 6.392

6.  Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  R V Bijl; A Ravelli; G van Zessen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-12       Impact factor: 4.328

7.  Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.

Authors:  Joseph F Goldberg; Roy H Perlis; S Nassir Ghaemi; Joseph R Calabrese; Charles L Bowden; Stephen Wisniewski; David J Miklowitz; Gary S Sachs; Michael E Thase
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

Review 8.  ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Authors:  Guy M Goodwin; Ian Anderson; Celso Arango; Charles L Bowden; Chantal Henry; Philip B Mitchell; Willem A Nolen; Eduard Vieta; Hans-Ulrich Wittchen
Journal:  Eur Neuropsychopharmacol       Date:  2008-05-23       Impact factor: 4.600

Review 9.  Bipolar II disorder: arguments for and against a distinct diagnostic entity.

Authors:  Eduard Vieta; Trisha Suppes
Journal:  Bipolar Disord       Date:  2008-02       Impact factor: 6.744

Review 10.  Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.

Authors:  R W Licht; H Gijsman; W A Nolen; J Angst
Journal:  Acta Psychiatr Scand       Date:  2008-08-26       Impact factor: 6.392

View more
  26 in total

1.  Bipolar II Disorder Is a Myth.

Authors:  Gin S Malhi; Tim Outhred; Lauren Irwin
Journal:  Can J Psychiatry       Date:  2019-05-06       Impact factor: 4.356

2.  Correlates, Course, and Outcomes of Increased Energy in Youth with Bipolar Disorder.

Authors:  Elisabeth A Frazier; Jeffrey I Hunt; Heather Hower; Richard N Jones; Boris Birmaher; Michael Strober; Benjamin I Goldstein; Martin B Keller; Tina R Goldstein; Lauren M Weinstock; Daniel P Dickstein; Rasim S Diler; Neal D Ryan; Mary Kay Gill; David Axelson; Shirley Yen
Journal:  J Affect Disord       Date:  2020-04-18       Impact factor: 4.839

3.  Atypical features and treatment choices in bipolar disorders: a result of the National Bipolar Mania Pathway Survey in China.

Authors:  Daihui Peng; Ting Shen; Linda Byrne; Chen Zhang; Yueqi Huang; Xin Yu; Jingping Zhao; Marita McCabe; David Mellor; Yiru Fang
Journal:  Neurosci Bull       Date:  2015-01-06       Impact factor: 5.203

4.  Differential diagnosis of major depression and bipolar disorder.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03       Impact factor: 5.270

Review 5.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

6.  Emotional status: diagnosis and treatment for severe psychiatric disorders.

Authors:  P Falkai; H-J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-02       Impact factor: 5.270

7.  Discriminating unipolar and bipolar depression by means of fMRI and pattern classification: a pilot study.

Authors:  Dominik Grotegerd; Thomas Suslow; Jochen Bauer; Patricia Ohrmann; Volker Arolt; Anja Stuhrmann; Walter Heindel; Harald Kugel; Udo Dannlowski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-26       Impact factor: 5.270

8.  Bipolar spectrum in major depressive disorders.

Authors:  J Angst; K R Merikangas; L Cui; A Van Meter; V Ajdacic-Gross; W Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-21       Impact factor: 5.270

9.  Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study.

Authors:  Rodrigo Machado-Vieira; David A Luckenbaugh; Elizabeth D Ballard; Ioline D Henter; Mauricio Tohen; Trisha Suppes; Carlos A Zarate
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

10.  Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity.

Authors:  J Angst; A Gamma; C L Bowden; J M Azorin; G Perugi; E Vieta; A H Young
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-01-31       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.